Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:06.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:14:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:20:21.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:32.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the lapse-in-funding notice about data currency.
    Difference
    0.4%
    Check dated 2026-02-11T05:56:46.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center status and a site revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:52:06.000Z thumbnail image

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.